ABCA3 and interstitial lung disease specific to childhood: Because most patients carry compound heterozygous ABCA3 mutations, making the study of individual mutations difficult, we focused on identifying infants and children carrying homozygous ABCA3 type 1 and type 2 mutations along with documented chILD clinical phenotypes.